MC

467.5

+2.76%↑

SANES

9.507

+5.79%↑

SAF

284.3

+4.37%↑

BBVA

18.305

+4.87%↑

BNP

82.81

+4.61%↑

MC

467.5

+2.76%↑

SANES

9.507

+5.79%↑

SAF

284.3

+4.37%↑

BBVA

18.305

+4.87%↑

BNP

82.81

+4.61%↑

MC

467.5

+2.76%↑

SANES

9.507

+5.79%↑

SAF

284.3

+4.37%↑

BBVA

18.305

+4.87%↑

BNP

82.81

+4.61%↑

MC

467.5

+2.76%↑

SANES

9.507

+5.79%↑

SAF

284.3

+4.37%↑

BBVA

18.305

+4.87%↑

BNP

82.81

+4.61%↑

MC

467.5

+2.76%↑

SANES

9.507

+5.79%↑

SAF

284.3

+4.37%↑

BBVA

18.305

+4.87%↑

BNP

82.81

+4.61%↑

Search

Elecnor SA

Open

BrancheFinanzen

31.25 8.32

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

28.7

Max

31.2

Schlüsselkennzahlen

By Trading Economics

Einkommen

18M

61M

Verkäufe

461M

2.4B

KGV

Branchendurchschnitt

22.443

54.048

Gewinnspanne

2.539

Angestellte

28,218

EBITDA

92M

146M

Dividenden

By Dow Jones

Nächstes Ergebnis

28. Apr. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

43M

2.5B

Vorheriger Eröffnungskurs

22.93

Vorheriger Schlusskurs

31.25

Nachrichtenstimmung

By Acuity

35%

65%

95 / 441 Ranking in Finance

Technischer Score

By Trading Central

Vertrauen

Strong Bullish Evidence

Elecnor SA Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

23. März 2026, 23:47 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23. März 2026, 22:55 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23. März 2026, 21:51 UTC

Akquisitionen, Fusionen, Übernahmen

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23. März 2026, 23:59 UTC

Market Talk

Global Equities Roundup: Market Talk

23. März 2026, 23:59 UTC

Market Talk

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23. März 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23. März 2026, 23:37 UTC

Market Talk

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23. März 2026, 22:42 UTC

Market Talk
Wichtige Nachrichtenereignisse

Global Equities Roundup: Market Talk

23. März 2026, 22:42 UTC

Market Talk
Wichtige Nachrichtenereignisse

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23. März 2026, 22:40 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23. März 2026, 22:23 UTC

Market Talk

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23. März 2026, 22:22 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23. März 2026, 22:21 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23. März 2026, 22:21 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23. März 2026, 22:20 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23. März 2026, 22:20 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23. März 2026, 22:19 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23. März 2026, 22:19 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23. März 2026, 22:18 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23. März 2026, 22:15 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23. März 2026, 22:08 UTC

Market Talk

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23. März 2026, 21:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23. März 2026, 21:42 UTC

Market Talk

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23. März 2026, 21:32 UTC

Ergebnisse

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23. März 2026, 21:32 UTC

Ergebnisse

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23. März 2026, 21:32 UTC

Ergebnisse

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23. März 2026, 21:10 UTC

Wichtige Nachrichtenereignisse

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23. März 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

23. März 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

23. März 2026, 20:50 UTC

Market Talk
Ergebnisse
Wichtige Nachrichtenereignisse

Basic Materials Roundup: Market Talk

Peer-Vergleich

Kursveränderung

Elecnor SA Prognose

Rating-Konsens

By TipRanks

0 ratings

0

Buy

0

Halten

0

Sell

Technischer Score

By Trading Central

18.36 / 20.25Unterstützung & Widerstand

Kurzfristig

Strong Bullish Evidence

Mittelfristig

Very Strong Bullish Evidence

Langfristig

Strong Bullish Evidence

Stimmung

By Acuity

95 / 441 Ranking in Finanzen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Elecnor SA

Elecnor, S.A. engages in the development, construction, and operation of projects and services in Spain and internationally. The company operates energy transports, conversion, and distribution; generates power from wind farms, as well as solar, combined cycle, biomass, and hydroelectric plants; and provides gas related services covering transmission of power generated by gas-fired plants, construction and maintenance of distribution pipelines, and comprehensive services, as well as compression, metering, and regulator stations. It also offers telecommunications infrastructure, systems and networks, automation and infrastructure control, smart cities, and industrial automation; catenary, substations, signalling and interlocks, communications, and remote control and control; and technical assistance, administrative support, network operations, live working, installation and equipment maintenance, and customer management services. In addition, the company provides electricity, HVAC, fire protection, ventilation, energy efficiency, automation and control, management systems, safety and security, public address and sound systems, telecommunications, and plumbing and sewer systems; site and building rehabilitation, installations, outfitting and equipment, ornamental lighting, and prefabs; Water resource planning and transport and distribution networks; environmental development and protection policies; and treatment and reuse of waste and sewerage and water purification services. Further, it involved in space services for energy and environment, aerospace, aeronautics and defence, transport, safety and security, building, industry, and telecommunications sectors. Elecnor, S.A. was incorporated in 1958 and is based in Madrid, Spain. Elecnor, S.A. is a subsidiary of Cantiles XXI, S.L.
help-icon Live chat